TransMedics (TMDX) Gains from Investment Securities (2018 - 2026)

TransMedics' Gains from Investment Securities history runs 8 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 770.59% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $12.6 million (up 2783.49% YoY), while the FY2025 annual figure was $95723.0, down 96.55% from the prior year.
• Gains from Investment Securities was $3.8 million for Q1 2026 at TransMedics, down from $8.8 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $30.9 million in Q4 2023 to a low of $24000.0 in Q1 2024.
• Historically, Gains from Investment Securities has averaged $4.0 million across 5 years, with a median of $563327.5 in 2022.
• The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities soared 5224.76% in 2023, then plunged 92.65% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at $14.9 million in 2022, then jumped by 107.79% to $30.9 million in 2023, then slumped by 97.2% to $866112.0 in 2024, then jumped by 911.65% to $8.8 million in 2025, then plunged by 56.63% to $3.8 million in 2026.
• The last three Gains from Investment Securities figures came in at $3.8 million (Q1 2026), $8.8 million (Q4 2025), and $174260.0 (Q3 2025), per Business Quant data.